Optic Gliomas in Neurofibromatosis Type 1

Area of Science:

• Pediatric Ophthalmology
• Neuro-oncology
• Genetics

Background:

• Neurofibromatosis type 1 (NF1) is a genetic disorder associated with an increased risk of developing tumors, including optic gliomas.
• Optic gliomas in children with NF1 can lead to significant visual impairment and other complications if not diagnosed and managed early.

Purpose of the Study:

• To determine the incidence, clinical presentation, and outcomes of optic gliomas in children diagnosed with NF1.
• To evaluate the effectiveness of current screening practices for optic gliomas in this population.

Main Methods:

• A retrospective review of electronic medical records was conducted for patients diagnosed with NF1.
• Data on optic glioma diagnosis, patient demographics, symptoms, and treatment were extracted and analyzed.

Main Results:

• Of 708 children with NF1, 30 (4.2%) were diagnosed with optic glioma, with an average age of diagnosis at 5 years.
• Half of the patients presented with symptoms such as vision loss or proptosis; symptomatic children were diagnosed later than asymptomatic ones.
• Gliomas frequently involved the optic chiasm (53%) and were often bilateral (63%).

Conclusions:

• Screening for optic gliomas in children with NF1 is inconsistent, with many at-risk children lacking regular ophthalmologic visits.
• Early diagnosis through annual ophthalmologic examinations and precocious puberty screening is vital for reducing morbidity in children with NF1.
• Asymptomatic optic gliomas can occur early in children with NF1, underscoring the need for vigilant monitoring.